289 Aufrufe 289 0 Kommentare 0 Kommentare

    Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / September 20, 2024 / RedChip Companies will air interviews with Nova Minerals Limited (Nasdaq:NVA) and Soligenix Inc. (Nasdaq:SNGX) on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV, this …

    ORLANDO, FL / ACCESSWIRE / September 20, 2024 / RedChip Companies will air interviews with Nova Minerals Limited (Nasdaq:NVA) and Soligenix Inc. (Nasdaq:SNGX) on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV, this Saturday, September 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

    Access the interviews in their entirety at:

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Barrick Gold Corporation!
    Long
    18,76€
    Basispreis
    1,22
    Ask
    × 14,98
    Hebel
    Zum Produkt
    Short
    21,38€
    Basispreis
    1,31
    Ask
    × 13,95
    Hebel
    Zum Produkt
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Christopher Gerteisen, CEO of Nova Minerals, appears on the RedChip Small Stocks, Big Money show on Bloomberg TV to provide a corporate update. Nova Minerals presents a compelling investment opportunity for those seeking exposure to large-scale gold projects at a significant discount. With its flagship Estelle Gold Project in Alaska, the company holds a pit constrained S-K 1300 compliant resource of 5.2 million ounces (Moz) of gold and growing in a region renowned for Tier 1 gold deposits [Donlin Creek (45Moz Au); Fort Knox (11Moz Au); and Pogo (6.9Moz)]. Currently, NVA trades at an extremely low A$6 per ounce of gold on an enterprise value basis, compared to the sector average of A$70/oz. The ongoing metallurgical and flow sheet work for the Feasibility Study (FS) is expected to further optimize project economics, with the potential to incorporate innovative processing techniques and additional near-term revenue from surface level critical minerals like antimony. With a clear pathway to permitting, strong exploration potential, and a Feasibility Study under way, which is expected to deliver strong economic results with both gold and antimony prices currently at all-time highs, Nova Minerals offers a high-upside, underappreciated asset for investors looking for growth in the gold and critical minerals sectors.

    Christopher J. Schaber, PhD, President and CEO of Soligenix, appears on the RedChip Small Stocks Big Money show on Bloomberg TV to provide a corporate update. Soligenix, a late-stage biopharmaceutical company, showcases a strong portfolio with several products in advanced clinical stages, targeting a potential $2 billion in annual global sales. Notable among these is HyBryte, a photodynamic therapy for cutaneous T-cell lymphoma (CTCL), a rare chronic cancer, which has demonstrated positive results in a Phase 3 study published in JAMA Dermatology. The company is gearing up for a follow-up confirmatory Phase 3 study, with HyBryte's market potential estimated at $250 million. Additional promising assets include SGX302, aimed at treating psoriasis, currently in a Phase 2a trial with a market potential exceeding $1 billion, and SGX945 for Behçet's Disease, with a Phase 2a set to begin later this year. Moreover, Soligenix has secured collaborations across biotech, academia, and government to advance its public health pipeline, highlighted by non-dilutive funding and NIH grants supporting vaccine development. Recently, impressive data from its filovirus vaccine program has been published, showing complete protection in non-human primates against certain deadly viruses, with the FDA granting orphan drug designations. These developments position Soligenix as a compelling investment opportunity, with a strategic focus on unmet medical needs, robust partnership backing, and multiple potential upside catalysts expected in the next 6-12 months and beyond.

    Seite 1 von 3



    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen

    Verfasst von Accesswire
    Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV ORLANDO, FL / ACCESSWIRE / September 20, 2024 / RedChip Companies will air interviews with Nova Minerals Limited (Nasdaq:NVA) and Soligenix Inc. (Nasdaq:SNGX) on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV, this …